New NIHR evidence synthesis groups give major boost to the UK NSC
The National Institute for Health Research is investing millions of pounds to provide the UK NSC with dedicated research expertise.
General
Final data analysis under way to inform SCID screening recommendation
Well over 1 million babies have now been screened for severe combined immune deficiency (SCID) since the September 2021 launch of an in-service evaluation (ISE) in NHS services.
How the UK NSC stays up to date with health screening innovations
Article alert system helps ensure the UK NSC stays up to date with the latest scientific developments in health screening.
SMA Screening ISE Partnership Board update February 2025
An update from the partnership board that is overseeing the planning of an in-service evaluation (ISE) of newborn screening for spinal muscular atrophy.
More than 200 stakeholders attend UK NSC seminar on multi-cancer detection tests
More than 200 stakeholders attended a fascinating UK National Screening Committee (UK NSC) seminar exploring multi-cancer detection tests (MCDs) and their potential use in a screening context. Attendees included academics, clinicians, researchers, industry representatives, patient organisations, screening providers, policy makers …
Please respond to UK NSC stakeholder survey
Please complete short survey to help us improve the way the UK NSC involves stakeholders and the public in its work.
What role do local public health teams play in screening?
Find out more about the role local government public health teams play in screening.
Attending master’s level module has expanded and deepened my understanding of screening
Cancer Research UK Strategic Evidence Manager Hope Walters talks about her experience of attending the Health Screening Module at the University of Warwick.
Experts discuss the challenges of using surrogate endpoints in cancer screening
Posted by:
Prof Bethany Shinkins, Samantha Harrison and Hope Walters, Posted on:
-
Categories:
General
Experts discussed the potential role and challenges of surrogate endpoints in cancer screening in a webinar hosted by Cancer Research UK and Consilium Scientific.
The Generation Study: exploring genome sequencing in newborns
Amanda Pichini, Clinical Director at Genomics England, explains how the Generation Study hopes to provide evidence to inform future screening approaches.